These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36327053)

  • 21. Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008-2011).
    Hong KS; Kim MC; Ahn JH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1005-1014. PubMed ID: 32440112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease.
    Golabi P; Gerber L; Paik JM; Deshpande R; de Avila L; Younossi ZM
    JHEP Rep; 2020 Dec; 2(6):100171. PubMed ID: 32964202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V.
    Hong J; Shin WK; Lee JW; Lee SY; Kim Y
    Metab Syndr Relat Disord; 2022 May; 20(4):210-218. PubMed ID: 35100057
    [No Abstract]   [Full Text] [Related]  

  • 24. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Stratification for Sarcopenic Obesity in Subjects With Nonalcoholic Fatty Liver Disease.
    Chun HS; Lee M; Lee HA; Lee S; Kim S; Jung YJ; Lee C; Kim H; Lee HA; Kim HY; Yoo K; Kim TH; Ahn SH; Kim SU
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2298-2307.e18. PubMed ID: 36462755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study.
    Han E; Chun HS; Lee YH; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Lee BW; Kang ES; Cha BS; Ahn SH; Kim SU
    J Gastroenterol Hepatol; 2023 Sep; 38(9):1598-1609. PubMed ID: 37321651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease.
    Navarroza AMC; Wong SN
    Indian J Gastroenterol; 2021 Aug; 40(4):380-388. PubMed ID: 34213749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of low muscle mass associated with obesity in the USA.
    Murdock DJ; Wu N; Grimsby JS; Calle RA; Donahue S; Glass DJ; Sleeman MW; Sanchez RJ
    Skelet Muscle; 2022 Dec; 12(1):26. PubMed ID: 36539856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease.
    Rigor J; Vasconcelos R; Lopes R; Moreira T; Barata P; Martins-Mendes D
    Minerva Gastroenterol (Torino); 2023 Sep; 69(3):374-381. PubMed ID: 35343663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
    Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
    Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease.
    Chun HS; Kim MN; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1168-1178. PubMed ID: 34337887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease.
    Jo IH; Song DS; Chang UI; Yang JM
    Sci Rep; 2023 Apr; 13(1):6920. PubMed ID: 37117864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A significant association of non-obese non-alcoholic fatty liver disease with sarcopenic obesity.
    Kashiwagi K; Takayama M; Fukuhara K; Shimizu-Hirota R; Chu PS; Nakamoto N; Inoue N; Iwao Y; Kanai T
    Clin Nutr ESPEN; 2020 Aug; 38():86-93. PubMed ID: 32690183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Lee YH; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH
    Hepatology; 2016 Mar; 63(3):776-86. PubMed ID: 26638128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease.
    Iwaki M; Kobayashi T; Nogami A; Saito S; Nakajima A; Yoneda M
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lean nonalcoholic fatty liver disease and sarcopenia.
    Chen M; Cao Y; Ji G; Zhang L
    Front Endocrinol (Lausanne); 2023; 14():1217249. PubMed ID: 37424859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study.
    Lee HJ; Lee DC; Kim CO
    Front Endocrinol (Lausanne); 2021; 12():599339. PubMed ID: 33868162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey.
    Moon JH; Koo BK; Kim W
    J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):964-972. PubMed ID: 34080327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.